Nevro (NYSE: NVRO) is up 24% after announcing a monster third quarter earnings report and also increasing their financial guidance for worldwide revenue in 2019....
Nevro Corp. (NYSE: NVRO), a global medical device company that provides innovative, evidence-based solutions for the treatment of chronic pain, today announced it has received approval from the U.S. Food and Drug Administration (FDA) for the Senza Omnia Spinal Cord Stimulation (SCS) System...
Medtronic plc (NYSE:MDT) today announced four-year data from the IN.PACT Global study, which reinforce the long-term durability and safety of the IN.PACT™ Admiral™ drug-coated balloon (DCB) in patients with peripheral artery disease (PAD) in the superficial femoral (SFA) and popliteal arteries...
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced commercial availability of the Shockwave S4 Peripheral IVL Catheter...
'Merger Monday' continues to live up to its as Stryker announced that they have acquired Wright Medical for $4 billion, or $30.75 per share, which is a 52% premium over the volume-weighted average closing price of Wright's stock over the 30-day period ending on Oct. 31. ...
Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today reported financial results for the third quarter ended September 30, 2019....
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices, today announced the first U.S.-based implantation of the Axonics r-SNM® System subsequent...
Three cardiac surgeons at Cleveland Clinic, Hackensack Meridian Health and Cedars-Sinai Medical Center are the first in the United States to implant Abiomed’s (NASDAQ: ABMD) newest heart pump, the Impella 5.5 with SmartAssist....
Align Technology, Inc. (NASDAQ: ALGN) today announced a new Invisalign product offering to empower doctors with new tools and technology to better serve the rapidly expanding market for clear aligner treatment, especially with consumers who are looking for more moderate teeth straightening options....
Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported second quarter fiscal 2020 revenue of $205.0 million, an increase of 13% compared to revenue of $181.8 million for the same period of fiscal...